4//SEC Filing
EYETECH PHARMACEUTICALS INC 4
Accession 0001293941-05-000054
CIK 0001115285operating
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:27 PM ET
Size
14.1 KB
Accession
0001293941-05-000054
Insider Transaction Report
Form 4
SBLENDORIO GLENN
Chief Financial Officer
Transactions
- Sale
Common Stock
2005-07-01$12.59/sh−1,850$23,292→ 43,095 total - Exercise/Conversion
Incentive Stock Option (right to buy)
2005-07-01−1,850→ 62,329 totalExercise: $1.36From: 2002-02-21Exp: 2012-02-21→ Common Stock (1,850 underlying) - Exercise/Conversion
Common Stock
2005-07-01$1.36/sh+1,850$2,516→ 44,945 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2005-07-01−1,850→ 117,771 totalExercise: $1.36From: 2002-02-21Exp: 2012-02-21→ Common Stock (1,850 underlying)
Footnotes (1)
- [F1]Transaction effected pursuant to a 10b5-1 plan dated April 25, 2005.
Documents
Issuer
EYETECH PHARMACEUTICALS INC
CIK 0001115285
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001115285
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:27 PM ET
- Size
- 14.1 KB